SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001649325-15-000006
Filing Date
2015-07-28
Accepted
2015-07-28 16:11:56
Documents
2
Period of Report
2015-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_143811430525865.html 3  
1 FORM 3 wf-form3_143811430525865.xml 3 1755
2 POWER OF ATTORNEY - JP nephrogenexform3jaikrishna.htm EX-24 11344
  Complete submission text file 0001649325-15-000006.txt   14590
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Issuer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O NEPHROGENEX, INC. 3200 BEECHLEAF COURT, SUITE 900 RALEIGH NC 27604
Business Address
Patel Jaikrishna (Reporting) CIK: 0001649325 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36303 | Film No.: 151009824